Bio Plus Statistics

Total Valuation

Bio Plus has a market cap or net worth of KRW 475.68 billion. The enterprise value is 508.57 billion.

Market Cap	475.68B
Enterprise Value	508.57B

Important Dates

The next estimated earnings date is Thursday, May 15, 2025.

Earnings Date	May 15, 2025
Ex-Dividend Date	Dec 27, 2024

Share Statistics

Bio Plus has 58.87 million shares outstanding. The number of shares has decreased by -0.28% in one year.

Current Share Class	n/a
Shares Outstanding	58.87M
Shares Change (YoY)	-0.28%
Shares Change (QoQ)	-5.83%
Owned by Insiders (%)	32.71%
Owned by Institutions (%)	6.34%
Float	39.09M

Valuation Ratios

The trailing PE ratio is 32.72.

PE Ratio	32.72
Forward PE	n/a
PS Ratio	7.16
PB Ratio	3.12
P/TBV Ratio	3.78
P/FCF Ratio	n/a
P/OCF Ratio	17.96
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 18.88, with an EV/FCF ratio of -7.42.

EV / Earnings	35.94
EV / Sales	7.66
EV / EBITDA	18.88
EV / EBIT	21.49
EV / FCF	-7.42

Financial Position

The company has a current ratio of 0.71, with a Debt / Equity ratio of 0.37.

Current Ratio	0.71
Quick Ratio	0.57
Debt / Equity	0.37
Debt / EBITDA	2.07
Debt / FCF	-0.81
Interest Coverage	89.84

Financial Efficiency

Return on equity (ROE) is 12.06% and return on invested capital (ROIC) is 8.32%.

Return on Equity (ROE)	12.06%
Return on Assets (ROA)	6.77%
Return on Invested Capital (ROIC)	8.32%
Return on Capital Employed (ROCE)	15.11%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.30
Inventory Turnover	2.69

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +25.86% in the last 52 weeks. The beta is 0.60, so Bio Plus's price volatility has been lower than the market average.

Beta (5Y)	0.60
52-Week Price Change	+25.86%
50-Day Moving Average	7,236.60
200-Day Moving Average	6,310.33
Relative Strength Index (RSI)	63.01
Average Volume (20 Days)	753,905

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Bio Plus had revenue of KRW 66.41 billion and earned 14.15 billion in profits. Earnings per share was 246.92.

Revenue	66.41B
Gross Profit	42.53B
Operating Income	23.67B
Pretax Income	17.66B
Net Income	14.15B
EBITDA	26.94B
EBIT	23.67B
Earnings Per Share (EPS)	246.92

Full Income Statement

Balance Sheet

The company has 41.67 billion in cash and 55.66 billion in debt, giving a net cash position of -13.99 billion or -237.56 per share.

Cash & Cash Equivalents	41.67B
Total Debt	55.66B
Net Cash	-13.99B
Net Cash Per Share	-237.56
Equity (Book Value)	152.40B
Book Value Per Share	2,355.56
Working Capital	-30.85B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 26.49 billion and capital expenditures -95.00 billion, giving a free cash flow of -68.51 billion.

Operating Cash Flow	26.49B
Capital Expenditures	-95.00B
Free Cash Flow	-68.51B
FCF Per Share	-1,163.78

Full Cash Flow Statement

Margins

Gross margin is 64.05%, with operating and profit margins of 35.64% and 21.31%.

Gross Margin	64.05%
Operating Margin	35.64%
Pretax Margin	26.60%
Profit Margin	21.31%
EBITDA Margin	40.56%
EBIT Margin	35.64%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 50.00, which amounts to a dividend yield of 0.64%.

Dividend Per Share	50.00
Dividend Yield	0.64%
Dividend Growth (YoY)	-28.57%
Years of Dividend Growth	n/a
Payout Ratio	29.66%
Buyback Yield	0.28%
Shareholder Yield	0.93%
Earnings Yield	2.97%
FCF Yield	-14.40%

Dividend Details

Stock Splits

The last stock split was on November 23, 2022. It was a forward split with a ratio of 4.

Last Split Date	Nov 23, 2022
Split Type	Forward
Split Ratio	4

Scores

Bio Plus has an Altman Z-Score of 2.68. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.68
Piotroski F-Score	n/a